Literature DB >> 22661428

Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.

Hannes Hahne1, Amin Moghaddas Gholami, Bernhard Kuster.   

Abstract

The attachment of N-acetylglucosamine to serine or threonine residues (O-GlcNAc) is a post-translational modification on nuclear and cytoplasmic proteins with emerging roles in numerous cellular processes, such as signal transduction, transcription, and translation. It is further presumed that O-GlcNAc can exhibit a site-specific, dynamic and possibly functional interplay with phosphorylation. O-GlcNAc proteins are commonly identified by tandem mass spectrometry following some form of biochemical enrichment. In the present study, we assessed if, and to which extent, O-GlcNAc-modified proteins can be discovered from existing large-scale proteome data sets. To this end, we conceived a straightforward O-GlcNAc identification strategy based on our recently developed Oscore software that automatically analyzes tandem mass spectra for the presence and intensity of O-GlcNAc diagnostic fragment ions. Using the Oscore, we discovered hundreds of O-GlcNAc peptides not initially identified in these studies, and most of which have not been described before. Merely re-searching this data extended the number of known O-GlcNAc proteins by almost 100 suggesting that this modification exists even more widely than previously anticipated and the modification is often sufficiently abundant to be detected without enrichment. However, a comparison of O-GlcNAc and phospho-identifications from the very same data indicates that the O-GlcNAc modification is considerably less abundant than phosphorylation. The discovery of numerous doubly modified peptides (i.e. peptides with one or multiple O-GlcNAc or phosphate moieties), suggests that O-GlcNAc and phosphorylation are not necessarily mutually exclusive, but can occur simultaneously at adjacent sites.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661428      PMCID: PMC3494142          DOI: 10.1074/mcp.M112.019463

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  31 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.

Authors:  Keith Vosseller; Jonathan C Trinidad; Robert J Chalkley; Christian G Specht; Agnes Thalhammer; Aenoch J Lynn; June O Snedecor; Shenheng Guan; Katalin F Medzihradszky; David A Maltby; Ralf Schoepfer; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2006-02-01       Impact factor: 5.911

3.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.

Authors:  Won Ho Yang; Ji Eun Kim; Hyung Wook Nam; Jung Won Ju; Hoe Suk Kim; Yu Sam Kim; Jin Won Cho
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

4.  A novel two-stage tandem mass spectrometry approach and scoring scheme for the identification of O-GlcNAc modified peptides.

Authors:  Hannes Hahne; Bernhard Kuster
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-26       Impact factor: 3.109

5.  Localization of O-glycosylation sites in peptides by electron capture dissociation in a Fourier transform mass spectrometer.

Authors:  E Mirgorodskaya; P Roepstorff; R A Zubarev
Journal:  Anal Chem       Date:  1999-10-15       Impact factor: 6.986

6.  Epigenetics gets sweeter: O-GlcNAc joins the "histone code".

Authors:  John A Hanover
Journal:  Chem Biol       Date:  2010-12-22

Review 7.  Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation.

Authors:  Ping Hu; Shino Shimoji; Gerald W Hart
Journal:  FEBS Lett       Date:  2010-04-22       Impact factor: 4.124

8.  Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests.

Authors:  M J Huddleston; M F Bean; S A Carr
Journal:  Anal Chem       Date:  1993-04-01       Impact factor: 6.986

Review 9.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

Authors:  Gerald W Hart; Michael P Housley; Chad Slawson
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

10.  O-linked N-acetylglucosamine is present on the extracellular domain of notch receptors.

Authors:  Aiko Matsuura; Makiko Ito; Yuta Sakaidani; Tatsuhiko Kondo; Kosuke Murakami; Koichi Furukawa; Daita Nadano; Tsukasa Matsuda; Tetsuya Okajima
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

View more
  26 in total

Review 1.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

2.  PeptideShaker enables reanalysis of MS-derived proteomics data sets.

Authors:  Marc Vaudel; Julia M Burkhart; René P Zahedi; Eystein Oveland; Frode S Berven; Albert Sickmann; Lennart Martens; Harald Barsnes
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  Elucidating crosstalk mechanisms between phosphorylation and O-GlcNAcylation.

Authors:  Aneika C Leney; Dris El Atmioui; Wei Wu; Huib Ovaa; Albert J R Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

4.  O-Linked β-N-acetylglucosamine (O-GlcNAc) regulates emerin binding to barrier to autointegration factor (BAF) in a chromatin- and lamin B-enriched "niche".

Authors:  Jason M Berk; Sushmit Maitra; Andrew W Dawdy; Jeffrey Shabanowitz; Donald F Hunt; Katherine L Wilson
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

5.  Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM).

Authors:  Andrew N Lane; Richard M Higashi; Teresa W-M Fan
Journal:  Metabolomics       Date:  2016-06-29       Impact factor: 4.290

6.  Discovery of O-GlcNAc-6-phosphate modified proteins in large-scale phosphoproteomics data.

Authors:  Hannes Hahne; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-07-23       Impact factor: 5.911

7.  O-GlcNAcylation Antagonizes Phosphorylation of CDH1 (CDC20 Homologue 1).

Authors:  Jie Tian; Qizhi Geng; Yuehe Ding; Ji Liao; Meng-Qiu Dong; Xingzhi Xu; Jing Li
Journal:  J Biol Chem       Date:  2016-04-14       Impact factor: 5.157

Review 8.  Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination.

Authors:  Hai-Bin Ruan; Yongzhan Nie; Xiaoyong Yang
Journal:  Mol Cell Proteomics       Date:  2013-07-03       Impact factor: 5.911

9.  Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress.

Authors:  Albert Lee; Devin Miller; Roger Henry; Venkata D P Paruchuri; Robert N O'Meally; Tatiana Boronina; Robert N Cole; Natasha E Zachara
Journal:  J Proteome Res       Date:  2016-10-14       Impact factor: 4.466

Review 10.  Glycosylation of the nuclear pore.

Authors:  Bin Li; Jennifer J Kohler
Journal:  Traffic       Date:  2014-02-13       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.